Virus-Like Particles as an Immunogenic Platform for Cancer Vaccines by Jerri C. Caldeira, Michael Perrine, Federica Pericle, Federica Cavallo

Get full text

853 Evofosfomide potentiates the efficacy of a novel anti-PD-L1/PD-L2 monoclonal antibody against immune excluded tumors by Michael Curran, James Barlow, Ahmad Salameh, Paul Blezinger, Christine Gagliardi, Matt Hemberger, Federica Pericle

829 A potent STING agonist in combination with a novel anti-PD-L1/PD-L2 antibody leads to significant tumor responses in checkpoint-refractory cancers by Michael Curran, James Barlow, Manuela Iezzi, Laura Conti, Elisabetta Bolli, Federica Cavallo, Ahmad Salameh, Paul Blezinger, Christine Gagliardi, Federica Pericle, Chiara Cossu

A Virus-Like-Particle immunotherapy targeting Epitope-Specific anti-xCT expressed on cancer stem cell inhibits the progression of metastatic cancer in vivo by Elisabetta Bolli, John P. O'Rourke, Laura Conti, Stefania Lanzardo, Valeria Rolih, Jayne M. Christen, Giuseppina Barutello, Marco Forni, Federica Pericle, Federica Cavallo

Get full text

Development of a VLP-Based Vaccine Displaying an xCT Extracellular Domain for the Treatment of Metastatic Breast Cancer by Valeria Rolih, Jerri Caldeira, Elisabetta Bolli, Ahmad Salameh, Laura Conti, Giuseppina Barutello, Federica Riccardo, Jolanda Magri, Alessia Lamolinara, Karla Parra, Paloma Valenzuela, Giulio Francia, Manuela Iezzi, Federica Pericle, Federica Cavallo

Get full text